Blood Lymphocyte And Neutrophil Response Of Cultured Rainbow Trout, Oncorhynchus Mykiss, Administered Varying Dosages Of An Oral Immunomodulator – 'Fin-Immune™'

In a 10-week (May – August, 2008) Phase I trial, 840, 1+ rainbow trout, Oncorhynchus mykiss, received a commercial oral immunomodulator, Fin Immune™, at four different dosages (0, 10, 20 and 30 mg g-1) to evaluate immune response and growth. The overall objective of was to determine an optimal dosag...

Full description

Bibliographic Details
Main Authors: Barker, Duane, Holliday, John
Format: Text
Language:English
Published: Zenodo 2009
Subjects:
Raa
Online Access:https://dx.doi.org/10.5281/zenodo.1083287
https://zenodo.org/record/1083287